Question 1

Am I eligible for this trial based on my current health condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tadalafil for Sarcoidosis Associated Pulmonary Hypertension clinical trial (NCT01324999). Contact the study team or your healthcare provider for specific answers.

Question 2

How does tadalafil compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tadalafil for Sarcoidosis Associated Pulmonary Hypertension clinical trial (NCT01324999). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of tadalafil I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tadalafil for Sarcoidosis Associated Pulmonary Hypertension clinical trial (NCT01324999). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tadalafil for Sarcoidosis Associated Pulmonary Hypertension clinical trial (NCT01324999). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the expected duration of treatment in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tadalafil for Sarcoidosis Associated Pulmonary Hypertension clinical trial (NCT01324999). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my current medications affect my eligibility for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Tadalafil for Sarcoidosis Associated Pulmonary Hypertension clinical trial (NCT01324999). Contact the study team or your healthcare provider for specific answers.

What this study is about